Title |
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|
---|---|
Published in |
New England Journal of Medicine, June 2020
|
DOI | 10.1056/nejmoa2016638 |
Pubmed ID | |
Authors |
David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, Katelyn A Pastick, Sarah M Lofgren, Elizabeth C Okafor, Caleb P Skipper, Alanna A Nascene, Melanie R Nicol, Mahsa Abassi, Nicole W Engen, Matthew P Cheng, Derek LaBar, Sylvain A Lother, Lauren J MacKenzie, Glen Drobot, Nicole Marten, Ryan Zarychanski, Lauren E Kelly, Ilan S Schwartz, Emily G McDonald, Radha Rajasingham, Todd C Lee, Kathy H Hullsiek |
X Demographics
The data shown below were collected from the profiles of 7,913 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1659 | 21% |
Brazil | 420 | 5% |
France | 310 | 4% |
Canada | 226 | 3% |
Spain | 202 | 3% |
United Kingdom | 179 | 2% |
Mexico | 159 | 2% |
India | 142 | 2% |
Australia | 80 | 1% |
Other | 914 | 12% |
Unknown | 3622 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6407 | 81% |
Scientists | 799 | 10% |
Practitioners (doctors, other healthcare professionals) | 557 | 7% |
Science communicators (journalists, bloggers, editors) | 145 | 2% |
Unknown | 5 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,606 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1606 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 183 | 11% |
Student > Bachelor | 165 | 10% |
Other | 151 | 9% |
Student > Master | 151 | 9% |
Student > Ph. D. Student | 98 | 6% |
Other | 382 | 24% |
Unknown | 476 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 506 | 32% |
Biochemistry, Genetics and Molecular Biology | 103 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 96 | 6% |
Nursing and Health Professions | 66 | 4% |
Agricultural and Biological Sciences | 47 | 3% |
Other | 229 | 14% |
Unknown | 559 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10594. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2024.
All research outputs
#159
of 25,830,005 outputs
Outputs from New England Journal of Medicine
#17
of 32,698 outputs
Outputs of similar age
#17
of 434,673 outputs
Outputs of similar age from New England Journal of Medicine
#2
of 335 outputs
Altmetric has tracked 25,830,005 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,698 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 123.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,673 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 335 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.